Kuvaus

Ganciclovir – Antiviral for Cytomegalovirus (CMV) Infections (Rx)

Ganciclovir is a broad-spectrum antiviral medication primarily used for the treatment and prevention of cytomegalovirus (CMV) infections, especially in immunocompromised patients such as transplant recipients or individuals with advanced HIV infection.

It is a nucleoside analogue antiviral that works by inhibiting viral DNA polymerase, thereby blocking viral replication and limiting the spread of infection within the body.

Ganciclovir is commonly used for CMV retinitis, CMV pneumonia, and systemic CMV infections, and may also be used prophylactically in high-risk patients.

Tärkeimmät tiedot

• Active Ingredient: Ganciclovir
• Drug Class: Antiviral (nucleoside analogue)
• Käyttöaiheet:
  • Cytomegalovirus (CMV) infections
  • CMV retinitis
  • CMV prophylaxis in transplant patients
• Mechanism of Action: Inhibits viral DNA polymerase → prevents viral replication
• Reseptistatus: Vain reseptillä myytävä lääke

Määrittelyt

• Annostusmuodot
  • Intravenous (IV) infusion
  • Ophthalmic gel (for CMV-related eye infections in some cases)
• Yleiset vahvuudet:
  • IV: 500 mg vials
  • Ophthalmic gel: 0.15%
• Administration: IV infusion or topical (eye) application
• Dosing Frequency: Typically every 12 hours (induction), then maintenance dosing
• Onset of Action: Rapid after IV administration
• Half-Life: ~3–4 hours (longer in renal impairment)
• Metabolism: Minimal
• Erittyminen: Pääasiassa renaalinen (muuttumaton lääkeaine)
• Storage: Store as directed; reconstituted solutions used promptly

Annostus ja antotapa

• Induction therapy: Higher doses for initial viral suppression
• Maintenance therapy: Lower doses to prevent relapse
• Dose adjustment required in renal impairment
• Requires close monitoring (blood counts, renal function)

Yhteensopivuus / Soveltuvuus

• Patients with confirmed CMV infection
• Immunocompromised individuals (e.g., transplant recipients, HIV patients)
• Suitable for hospital or specialist-managed care
• May be used for prophylaxis in high-risk cases

Why Choose Ganciclovir?

Ganciclovir remains a first-line antiviral therapy for CMV infections, especially in high-risk and immunocompromised patients. Its targeted mechanism and proven efficacy make it essential in infectious disease and transplant medicine.